Description

According to a report by StrategyHelix, the global pemphigus vulgaris market is set to increase by US$ 183.8 million during 2022-2028, growing at a CAGR of 7.1% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for pemphigus vulgaris. The global pemphigus vulgaris market is segmented on the basis of treatment type, route of administration, end user, and region. On the basis of treatment type, the global pemphigus vulgaris market has been segmented into biological therapies, corticosteroids, immunosuppressants, intravenous immunoglobulin (IVIG), others. By route of administration, the global pemphigus vulgaris market has been segmented into intravenous, oral, subcutaneous. Based on end user, the global pemphigus vulgaris market is categorized into academic & research institutes, hospitals, specialty dermatology clinics. Geographically, the global pemphigus vulgaris market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global pemphigus vulgaris market is highly competitive. The leading players in the pemphigus vulgaris market include Almirall S.A., argenx SE, Biogen Inc., F. Hoffmann-La Roche AG, Novartis AG, Pfizer Inc., Principia Biopharma Inc., Sanofi S.A., Syntimmune Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pemphigus vulgaris market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Treatment type: biological therapies, corticosteroids, immunosuppressants, intravenous immunoglobulin (IVIG), others
Route of administration: intravenous, oral, subcutaneous
End user: academic & research institutes, hospitals, specialty dermatology clinics
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global pemphigus vulgaris market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Pemphigus vulgaris market overview
Part 3. Market breakdown by treatment type
– Biological therapies
– Corticosteroids
– Immunosuppressants
– Intravenous immunoglobulin (IVIG)
– Others
Part 4. Market breakdown by route of administration
– Intravenous
– Oral
– Subcutaneous
Part 5. Market breakdown by end user
– Academic & research institutes
– Hospitals
– Specialty dermatology clinics
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Almirall, S.A.
– argenx SE
– Biogen Inc.
– F. Hoffmann-La Roche AG
– Novartis AG
– Pfizer Inc.
– Principia Biopharma Inc.
– Sanofi S.A.
– Syntimmune Inc.
About StrategyHelix
Disclaimer